Page 177 - Aet News Today

Eli Lilly is paying $40 million up front for rights to a Confo Therapeutics drug in Phase 1 testing as a potential treatment for neuropathic pain. Confo develops drugs that target G-protein coupled receptors.

Disgruntled investors lodged fewer securities claims against life-science companies last year. But when they did sue, investors raised familiar issues, often tied to bad news around clinical research and regulatory approvals, according to a law firm report

Despite ketamine-assisted therapy being approved for treating several mental health conditions, it's generally not covered by insurance or employers. Though that likely won't always be the case, as psychedelics gather more research and employers notice the benefits for their workplaces.

When asked what the biggest threats facing them were, 94% of employers said high-cost pharmacy claims, 91% said medical inflation and 91% said million dollar treatments being approved by the FDA, according to a new survey from the Midwest Business Group on Health.

About 73% of benefits leaders believe their company has increased employee mental health support, a new survey found. Yet, many managers and employees disagree, showing a disconnect in perceptions.

MorphoSys’s emphasis on its clinical-stage cancer programs puts the spotlight on a myelofibrosis drug candidate from its 2021 acquisition of Constellation Pharmaceuticals. That small molecule could compete against drug candidates from GSK and Merck.

A California lawmaker recently introduced legislation designed to keep the state’s small and rural hospitals from closing as they work to meet seismic safety compliance requirements. The bill would require California’s Department of Health Care Access and Administration to provide grant funding to small and rural hospitals so they can achieve compliance amid times of severe financial distress

Valuable digital data is a relatively new phenomenon in the history of healthcare. Providers need to think of it in a new way — not as a byproduct, but as another valuable outcome they are generating as they do their jobs and care for patients.

In the two years since its launch, Hackensack Meridian Health's violence prevention program has provided medical, financial and emotional aid to more than 400 victims of violence. Government officials have taken note of this — the program recently gained $3 million in federal and state grants.

Abridge announced the largest deployment of its technology to date — the University of Kansas Health System will adopt the software for more than 1,500 of its physicians across 140 locations. The startup's technology listens to visits and creates a near-instant summary that adheres to physicians' prototypical note structure.